A recent article in the New England Journal of Medicine’s Catalyst publication — co-authored by Laura Kaiser, FACHE, Intermountain’s Executive Vice President and Chief Operating Officer, and Thomas Lee, MD, Chief Medical Officer of Press Ganey Associates — takes on the challenging question of how integrated health systems like Intermountain...
Verified link by Valmet Tissue Converting Solutions
Pharma’s Role In Value-Based Care Information Center
Get comprehensive updates, key reports, and detailed insights compiled from verified editorial sources.
Overview on Pharma’s Role In Value-Based Care
A recent article in the New England Journal of Medicine’s Catalyst publication — co-authored by Laura Kaiser, FACHE, Intermountain’s Executive Vice President and Chief Operating Officer, and Thomas Lee, MD, Chief Medical Officer of Press Ganey Associates — takes on the challenging question of how integrated health systems like Intermountain Healthcare can cope with skyrocketing prescription medication costs, and how the pharmaceuticals industry can become a partner in the pursuit of value-based care.
Main Features
Explore the primary sources for Pharma’s Role In Value-Based Care.
Developments
Stay updated on Pharma’s Role In Value-Based Care's latest milestones.
Featured Video Reports & Highlights
Below is a handpicked selection of video coverage, expert reports, and highlights regarding Pharma’s Role In Value-Based Care from verified contributors.
Pharma’s Role in Value-Based Care
Full Guide
Data is compiled from public records and verified media reports.
Last Updated: May 23, 2026
Future Outlook
For 2026, Pharma’s Role In Value-Based Care remains one of the most searched-for profiles. Check back for the newest reports.
Disclaimer:
